Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (2020 - 2025)

Maravai Lifesciences Holdings has reported Shares Outstanding over the past 6 years, most recently at $110.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $110.7 million for Q4 2025, down 22.04% from a year ago — trailing twelve months through Dec 2025 was $110.7 million (down 22.04% YoY), and the annual figure for FY2025 was $110.7 million, down 22.04%.
  • Shares Outstanding for Q4 2025 was $145.3 million at Maravai Lifesciences Holdings, roughly flat from $144.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for MRVI hit a ceiling of $161.0 million in Q1 2021 and a floor of $110.7 million in Q3 2024.
  • Median Shares Outstanding over the past 5 years was $131.7 million (2022), compared with a mean of $132.8 million.
  • Biggest five-year swings in Shares Outstanding: fell 23.17% in 2022 and later increased 20.88% in 2025.
  • Maravai Lifesciences Holdings' Shares Outstanding stood at $131.5 million in 2021, then decreased by 5.95% to $123.7 million in 2022, then rose by 6.92% to $132.2 million in 2023, then increased by 7.37% to $142.0 million in 2024, then dropped by 22.04% to $110.7 million in 2025.
  • The last three reported values for Shares Outstanding were $110.7 million (Q4 2025), $110.7 million (Q3 2025), and $144.6 million (Q2 2025) per Business Quant data.